Description: Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Home Page: www.lauruslabs.com
Serene Chambers
Hyderabad,
500034
India
Phone:
91 40 3980 4333
Officers
| Name | Title |
|---|---|
| Dr. Satyanarayana Chava M.Sc., Ph.D. | CEO & Whole Time Director |
| Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A. | CFO & Whole-Time Director |
| Mr. B. V. R. K. Suryadevara Srinivasa Rao | Executive Vice President of Manufacturing & Operations |
| Mr. Narasimha Rao Chava | Executive Vice President of Human Resources |
| Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D. | Head of Quality & Executive Director |
| Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc. | Executive Vice President of Manufacturing |
| Mr. Chagarlamudi Sita Ramaiah | Executive Vice President of Finance |
| Mr. Dammalapati Venkata Lakshmi Narasimha Rao | Executive Vice President of Synthesis |
| Mr. Krishna Chaitanya Chava | Executive VP, Head of Synthesis & Ingredients and Executive Director |
| Mr. Rajaram Iyer M.B.A. | Executive Vice President of Portfolio Management |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 243.6983 |
| Price-to-Book MRQ: | 7.6917 |
| Price-to-Sales TTM: | 6.31 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 6007 |